The Benelux nuclear imaging systems market size is expected to reach US$ 98.5 million by 2031 from US$ 78.8 million in 2024. The market is estimated to record a CAGR of 3.2% from 2025 to 2031.
Executive Summary and Benelux Nuclear Imaging Systems Market Analysis:
The nuclear imaging market in the Benelux region is highly advanced and established owing to stable investment in the healthcare system. Benelux region which includes Belgium, the Netherlands, and Luxembourg, benefit from advanced medical infrastructure, encouraging uptake of newer imaging systems for early diagnosis and treatment planning. Hybrid scanners and radiopharmaceutical development are the two key areas driving this growth, especially in oncology and neurology. Universities and hospitals are engaged in partnering activities, whereas private diagnostic organizations are slowly upgrading their machinery to keep pace with clinical standards. The Netherlands is leading the way in day- to - day utilization, with support from local manufactures, research organizations, and integrated health care system. Belgium adds strength through its pharmaceutical expertise, and Luxembourg, though smaller, is gradually widening access to advanced diagnostics. Due to the small size of the region and interconnections of the health systems, cross-border use is routine, making Benelux a usable focal point for nuclear imaging for the wider Western European region.
Benelux Nuclear Imaging Systems Market Strategic Insights
Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.
- By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
- By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.
Benelux Nuclear Imaging Systems Market Outlook
Hospitals and diagnostic centers are increasingly utilizing PET/CT and SPECT/CT systems, mainly to expedite diagnosis and treatment for cancer and cardiovascular disease. A major factor for this momentum is investment in digital systems that link the scans to the electronic health record, allowing physicians to quickly share and read results. The Netherlands is leading the way, with several hospitals pilot-testing AI tools to help standardize reports and minimize variability. Furthermore, the supply of radiopharmaceuticals is more stable than in other regions of Europe, with local universities and companies partnering to produce radiopharmaceuticals and leisure radiotracer studies. As healthcare budgets tighten, providers are maximizing the value of each scan—prompting a shift toward outpatient nuclear imaging and a stronger emphasis on personalized care pathways.
Benelux Nuclear Imaging Systems Market Country Insights
Based on country, the Benelux nuclear imaging systems market is segmented into Belgium, the Netherlands, and Luxembourg. The Netherlands held the largest share in 2024.
The Netherlands is the leading Benelux nuclear imaging systems market, offering advanced infrastructures for healthcare and a significant emphasis on innovations in diagnostic frameworks. Key hospitals and academic institutions are installing advanced detail-oriented PET/MRI systems and SPECT/CT systems to assist in complex clinical assessments, particularly oncology and neurology. The Netherlands' commitment to integrated care has seen the dominant use of imaging platforms that allow for seamless connection with electronic health records. In addition to prominent international manufactures, including GE HealthCare, Siemens Healthineers, and Phillips, domestic manufactures have significant presence, supplying advanced systems and actively conducting joint research. The Netherlands’ radiopharmaceutical marketplace is well-regulated, and assured production and delivery of critical isotopes to support clinical and research needs. Expanding training programs in nuclear medicine demonstrate the desire to have a qualified workforce capable of operating and providing proficient interpretation of complex imaging modalities (e.g. nuclear systems). Moving forward, the Netherlands remains committed to quality, accessibility, and innovation, serving as the benchmark for nuclear imaging throughout the Benelux.
Benelux Nuclear Imaging Systems Market Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 78.8 Million |
| Market Size by 2031 | US$ 98.5 Million |
| CAGR (2025 - 2031) | 3.2% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Benelux | Belgium, Netherlands, Luxembourg |
| Market leaders and key company profiles |
|
Benelux Nuclear Imaging Systems Market Company Profiles
GE HealthCare, Siemens Healthineers AG, Canon Inc., Koninklijke Philips N.V., SHIMADZU CORPORATION, United Imaging Healthcare Co., Ltd., Neusoft Medical Systems Co., Ltd., Mediso Ltd., Positron Corporation, and MiE GmbH are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
Benelux Nuclear Imaging Systems Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Benelux Nuclear Imaging Systems Market Country and Regional Insights
Benelux Nuclear Imaging Systems Key Sources Referred:
- The World Bank
- World Health Organization (WHO)
- Center for Disease Control and Prevention (CDC)
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- European Association of Nuclear Medicine (EANM)
- American College of Nuclear Medicine (ACNM)
- American Society of Nuclear Cardiology (ASNC)
- Global Cancer Observatory
- Company website
- Company annual reports
- Company investor presentations
